Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

Mereo provides performance management, goals and compensation software. Its platform links corporate strategy to individual objectives and variable pay. Large Brazilian organisations use it for people performance cycles.

News

Press release The Globe and Mail 19 days ago
Mereo Biopharma Grants Sentynl Rights to Alvelestat Therapy
Detailed price information for Mereo Biopharma Group Plc ADR (MREO-Q) from The Globe and Mail including charting and trades.
Read more
Report
News markets.businessinsider.com 20 days ago
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
Entered into option and license agreement with Sentynl Therapeutics for alvelestat, Mereo's investigational oral therapy for Alpha-1 Antitrypsin D...
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.